已关闭
  • 顶部Banner位
  • 固定模块
设置
周年庆试用
企业管理端
周年庆试用
代理
【周年庆试用】【试用】Cellectra™系列CD4 T细胞纳米分选磁珠
收藏
分享
优势特色(Features) High Safety Raw Material Safety: The conjugated antibodies are recombinant antibodies, avoiding contamination from animal-derived viruses and exogenous factor pollutants. Medical-grade nanoparticles with dextran matrix coating - high biocompatibility, biodegradable. Supply Chain Safety: Highly integrated autonomous platforms for nano-magnetic beads and single B-cell antibody. Process Safety : AOF production process prevents exogenous factor contamination, with rigorous quality control ensuring product safety. High Sorting Purity Conjugated antibodies are derived from a single B-cell antibody development platform, featuring optimized antibody epitopes. Nanoscale superparamagnetic beads enable efficient and gentle cell sorting. Long-Term Stability Stable for 24 months at -20 °C or below. 产品描述(Product Description) Cellectra™ Human CD4 NanoSort Microbeads are dextran-coated superparamagnetic nanoparticles conjugated with recombinant monoclonal antibodies specific to human CD4. They are especially designed for positive or negative selection of CD4+ cells. The beads are manufactured under sterile ISO 5 conditions with no animal- or human-derived components. Each batch undergoes rigorous quality control, including sterility, endotoxin, and functional validation. 应用说明(Application) Cellectra™ Human CD4 NanoSort Microbeads are designed for the positive selection or negative selection of CD4+ T cells from fresh or frozen human peripheral blood mononuclear cells (PBMCs). CD4 is an accessory molecule in the recognition of MHC class II/peptide complexes by the TCR heterodimers on CD4+ T helper cells. It is predominantly expressed on the surface of T helper cells. The magnetic nBeads are conjugated with monoclonal antibodies targeting human CD4 protein, enabling CD4+ cells to be labeled with the specific antibodies and magnetic particles, and separated using the separation columns and magnets. 存储(Storage) For long term storage, the product should be stored in liquid state at -20°C or below. Stability upon receipt: Stable for 24 months at -20 °C or below; Stable for 9 months at 2-8 °C under sterile conditions. Please avoid repeated freeze-thaw cycles. 无菌(Sterility) Negative 内毒素(Endotoxin) Less than 2 EU per mL by the LAL method / rFC method. 支原体(Mycoplasma) Negative 注意事项(Important Note) This product is for research use only and not intended for therapeutic or in vivo diagnostic use. 制剂(Formulation) Please contact us for detailed information. Contact us for customized product form or formulation.
原料试剂 研发实验室
价格
¥3411.00
品牌 ACROBiosystems百普赛斯
地区 中国,北京,北京市
货号 MBS-S004
产地 国产
选择规格
MBS-S004-2ml
易享客服
ACROBiosystems百普赛斯
北京百普赛斯生物科技股份有限公司
北京
营业执照已审核
百普赛斯集团ACROBiosystems Group(股票代码:301080)是成立于2010年的跨国生物科技公司,是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球,横跨亚洲、北美洲、欧洲,在中国、美国、瑞士等国家的十余个城市设有办公室、研发中心及生产基地。目前累计服务客户超9000家,与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。 ACROBiosystems百普赛斯子品牌包括膜杰作、Star Staining、Aneuro、ComboX、ActiveMax、GENPower等,主要产品及服务包括蛋白、抗体、试剂盒及分析检测服务,应用于肿瘤、自身免疫疾病、心血管病、传染病、脑神经等疾病的药物筛选及优化、临床前实验及临床试验、药物生产过程及工艺控制(CMC)、诊断试剂开发及优化等研发及生产环节。 百普赛斯集团ACROBiosystems Group以加速生物药研发上市进程和服务于更好的临床应用为使命,愿通过自己的努力,从为客户带来价值开始,到为全球市场整个行业创造价值,公司不断通过更新技术、产品、服务,积极为合作伙伴赋能,来加速包括靶点药物和免疫治疗药物在内的,各种生物医药的研发上市进程和临床上更好的应用,最终为人类健康事业做出贡献。
进入店铺
产品规格 图文详情 技术文档
产品规格
品牌名称
ACROBiosystems百普赛斯
货号
MBS-S004
国产/进口
国产
规格
MBS-S004-2ml
储存条件
For long term storage, the product should be stored in liquid state at -20°C or below. Stability upon receipt: Stable for 24 months at -20 °C or below; Stable for 9 months at 2-8 °C under sterile cond
货源
新品
图文详情
技术文档
没有您想要的资料?去索要
返回顶部